Kirkman SK[au] - Search Results

Year	Number of Results
1967	2
1969	1
1973	1
1974	1
1978	1
1980	2
1981	1
1982	1
1986	1
1994	1
1998	1
2022	0

1

Metabolism and kinetics of oxaprozin in normal subjects.

Janssen FW, Jusko WJ, Chiang ST, Kirkman SK, Southgate PJ, Coleman AJ, Ruelius HW. Janssen FW, et al. Among authors: kirkman sk. Clin Pharmacol Ther. 1980 Mar;27(3):352-62. doi: 10.1038/clpt.1980.47. Clin Pharmacol Ther. 1980. PMID: 7357792

2

Isolation and identification of bromfenac glucoside from rat bile.

Kirkman SK, Zhang MY, Horwatt PM, Scatina J. Kirkman SK, et al. Drug Metab Dispos. 1998 Jul;26(7):720-3. Drug Metab Dispos. 1998. PMID: 9660857

3

Macro- and micromethods for high-performance liquid chromatographic analysis of oxaprozin in plasma.

McHugh SL, Kirkman SK, Knowles JA. McHugh SL, et al. Among authors: kirkman sk. J Pharm Sci. 1980 Jul;69(7):794-6. doi: 10.1002/jps.2600690712. J Pharm Sci. 1980. PMID: 7391941

4

Metabolic and pathologic investigation of 1-aminocyclohexanecarboxylic acid (ACHC), a metabolite of 6-(1-aminocyclohexanecarboxamido)-penicillanic acid (cyclacillin).

Janssen FW, Young EM, Kirkman SK, Agersborg HP Jr, Tucker WE Jr, Ruelius HW. Janssen FW, et al. Among authors: kirkman sk. Toxicol Appl Pharmacol. 1974 Jul;29(1):19-34. doi: 10.1016/0041-008x(74)90158-6. Toxicol Appl Pharmacol. 1974. PMID: 4378191 No abstract available.

5

Reactions of oxaprozin-1-O-acyl glucuronide in solutions of human plasma and albumin.

Ruelius HW, Kirkman SK, Young EM, Janssen FW. Ruelius HW, et al. Among authors: kirkman sk. Adv Exp Med Biol. 1986;197:431-41. doi: 10.1007/978-1-4684-5134-4_42. Adv Exp Med Biol. 1986. PMID: 3766273

6

Disposition of 4,5-diphenyl-2-oxazolepropionic acid (oxaprozin) in beagle dogs and rhesus monkeys.

Janssen FW, Kirkman SK, Knowles JA, Ruelius HW. Janssen FW, et al. Among authors: kirkman sk. Drug Metab Dispos. 1978 Jul-Aug;6(4):465-75. Drug Metab Dispos. 1978. PMID: 28928

7

Biotransformation of the immunomodulator, 3-(p-chlorophenyl)-2,3-dihydro-3-hydroxythiazolo[3,2a]benzimidazole-2-acetic acid, and its relationship to thyroid toxicity.

Janssen FW, Young EM, Kirkman SK, Sharma RN, Ruelius HW. Janssen FW, et al. Among authors: kirkman sk. Toxicol Appl Pharmacol. 1981 Jun 30;59(2):355-63. doi: 10.1016/0041-008x(81)90207-6. Toxicol Appl Pharmacol. 1981. PMID: 7256773 No abstract available.

8

Metabolic formation of N- and O-glucuronides of 3-(p-chlorophenyl)thiazolo[3,2-a]benzimidazole-2-acetic acid. Rearrangement of the 1-o-acyl glucuronide.

Janssen FW, Kirkman SK, Fenselau C, Stogniew M, Hofmann BR, Young EM, Ruelius HW. Janssen FW, et al. Among authors: kirkman sk. Drug Metab Dispos. 1982 Nov-Dec;10(6):599-604. Drug Metab Dispos. 1982. PMID: 6130907

9

Effect of L-valine on renal excretion, blood concentrations and toxicity of cycloleucine in mice.

Ruelius HW, Gregory FJ, Kirkman SK, Warren GH, Janssen FW. Ruelius HW, et al. Among authors: kirkman sk. Biochem Pharmacol. 1973 Jun 1;22(11):1379-83. doi: 10.1016/0006-2952(73)90311-0. Biochem Pharmacol. 1973. PMID: 4727787 No abstract available.

10

Determination of cycloleucine in biological fluids.

Janssen FW, Knowles JA, Kirkman SK, Ruelius HW. Janssen FW, et al. Among authors: kirkman sk. Anal Biochem. 1969 Aug;30(2):217-21. doi: 10.1016/0003-2697(69)90393-5. Anal Biochem. 1969. PMID: 5809664 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results